Synthetic Micro/Nanomotors for Drug Delivery
dc.contributor.author | Guzmán, Eduardo | |
dc.contributor.author | Maestro Martín, Armando | |
dc.date.accessioned | 2022-08-31T11:33:23Z | |
dc.date.available | 2022-08-31T11:33:23Z | |
dc.date.issued | 2022-08-17 | |
dc.identifier.citation | Technologies 10(4) : (2022) // Article ID 96 | es_ES |
dc.identifier.issn | 2227-7080 | |
dc.identifier.uri | http://hdl.handle.net/10810/57378 | |
dc.description.abstract | Synthetic micro/nanomotors (MNMs) are human-made machines characterized by their capacity for undergoing self-propelled motion as a result of the consumption of chemical energy obtained from specific chemical or biochemical reactions, or as a response to an external actuation driven by a physical stimulus. This has fostered the exploitation of MNMs for facing different biomedical challenges, including drug delivery. In fact, MNMs are superior systems for an efficient delivery of drugs, offering several advantages in relation to conventional carriers. For instance, the self-propulsion ability of micro/nanomotors makes possible an easier transport of drugs to specific targets in comparison to the conventional distribution by passive carriers circulating within the blood, which enhances the drug bioavailability in tissues. Despite the promising avenues opened by the use of synthetic micro/nanomotors in drug delivery applications, the development of systems for in vivo uses requires further studies to ensure a suitable biocompatibility and biodegradability of the fabricated engines. This is essential for guaranteeing the safety of synthetic MNMs and patient convenience. This review provides an updated perspective to the potential applications of synthetic micro/nanomotors in drug delivery. Moreover, the most fundamental aspects related to the performance of synthetic MNMs and their biosafety are also discussed. | es_ES |
dc.description.sponsorship | This work was funded in part by MICINN under Grant PID2019-106557GB-C21 and by E.U. on the framework of the European Innovative Training Network—Marie Sklodowska-Curie Action Nano Paint (Grant Agreement 955612). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/955612 | es_ES |
dc.relation | info:eu-repo/grantAgreement/MICINN/PID2019-106557GB-C21 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | biomedicine | es_ES |
dc.subject | drug delivery | es_ES |
dc.subject | machines | es_ES |
dc.subject | micro/nanomotors | es_ES |
dc.subject | nanomedicine | es_ES |
dc.subject | propulsion | es_ES |
dc.title | Synthetic Micro/Nanomotors for Drug Delivery | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2022-08-25T11:17:58Z | |
dc.rights.holder | © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/2227-7080/10/4/96 | es_ES |
dc.identifier.doi | 10.3390/technologies10040096 | |
dc.contributor.funder | European Commission |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).